CRNX vs FLS

Comparison between Crinetics Pharmaceuticals Inc (CRNX, Company) and Flowserve Corp (FLS, Company).

CRNX is from the Healthcare sector, while FLS is from the Industrials sector.

5-Year PerformanceCRNX has outperformed FLS, delivering a return of +31.8% compared to +12.6%

CRNX vs FLS - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	CRNX(COMPANY)	FLS(COMPANY)
Market Cap	$8.79B	$8.81B
Max Drawdown	68.70%	77.36%
Sharpe Ratio	1.20	0.73
5Y Beta	1.03	1.55
Industry	Biotechnology	Specialty Industrial Machinery
P/E Ratio	-16.36	19.67
Forward P/E	N/A	17.01
PEG Ratio	-0.47	0.23
Dividend Yield	N/A	1.23%
5Y Dividends CAGR	N/A	5.99%
5Y EPS CAGR	16.22%	24.01%
Debt to Equity	0.00%	77.52%
Free Cash Flow Yield	-4.77%	5.82%
P/S Ratio	489.28	1.90
P/B Ratio	3.48	4.18

Market Cap

CRNX

$8.79B

Winner

FLS

$8.81B

Max Drawdown

Winner

CRNX

68.70%

FLS

77.36%

Sharpe Ratio

Winner

CRNX

1.20

FLS

0.73

5Y Beta

Winner

CRNX

1.03

FLS

1.55

Industry

CRNX

Biotechnology

FLS

Specialty Industrial Machinery

P/E Ratio

Winner

CRNX

-16.36

FLS

19.67

Forward P/E

CRNX

N/A

FLS

17.01

PEG Ratio

Winner

CRNX

-0.47

FLS

0.23

Dividend Yield

CRNX

N/A

FLS

1.23%

5Y Dividends CAGR

CRNX

N/A

FLS

5.99%

5Y EPS CAGR

CRNX

16.22%

Winner

FLS

24.01%

Debt to Equity

Winner

CRNX

0.00%

FLS

77.52%

Free Cash Flow Yield

CRNX

-4.77%

Winner

FLS

5.82%

P/S Ratio

CRNX

489.28

Winner

FLS

1.90

P/B Ratio

Winner

CRNX

3.48

FLS

4.18

CRNX vs FLS - Historical Returns

Returns include dividend reinvestment.

Period	CRNX	FLS
1 month	+143.53%	-2.94%
3 months	+111.92%	-16.19%
6 months	+56.96%	-3.45%
1 year	+161.27%	+31.92%
5 years(CAGR)	+31.82%	+12.64%
10 years(CAGR)	N/A	+6.39%
Max(CAGR)	+16.62%	+11.26%

Winner

CRNX

+143.53%

FLS

-2.94%

Winner

CRNX

+111.92%

FLS

-16.19%

Winner

CRNX

+56.96%

FLS

-3.45%

Winner

CRNX

+161.27%

FLS

+31.92%

5Y(CAGR)

Winner

CRNX

+31.82%

FLS

+12.64%

10Y(CAGR)

CRNX

N/A

FLS

+6.39%

Max(CAGR)

Winner

CRNX

+16.62%

FLS

+11.26%

CRNX vs FLS - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	CRNX	FLS
2026	+78.86%	+0.26%
2025	-9.70%	+22.83%
2024	+44.48%	+44.37%
2023	+96.57%	+35.29%
2022	-35.36%	+1.67%
2021	+103.66%	-10.02%
2020	-44.45%	-25.24%
2019	-14.40%	+33.08%
2018	+22.36%	-9.01%
2017	N/A	-12.92%
2016	N/A	+16.21%
2015	N/A	-28.37%
2014	N/A	-19.84%
2013	N/A	+58.24%
2012	N/A	+45.71%
2011	N/A	-16.36%
2010	N/A	+24.27%
2009	N/A	+74.34%
2008	N/A	-44.96%
2007	N/A	+89.63%
2006	N/A	+23.37%
2005	N/A	+47.28%
2004	N/A	+32.28%
2003	N/A	+36.92%
2002	N/A	-44.00%
2001	N/A	+28.99%
2000	N/A	+30.05%
1999	N/A	-1.38%

CRNX vs FLS Drawdown Comparison

The maximum drawdown for CRNX was -68.70%, occurring on Mar 16, 2020. Recovery took 1326 trading sessions.

The maximum drawdown for FLS was -77.36%, occurring on Oct 10, 2002. Recovery took 819 trading sessions.

The current CRNX drawdown is -0.05%. The current FLS drawdown is -22.93%.

Rank	CRNX	FLS
#1	-68.70% Sep 12, 2018 - Dec 19, 2023	-77.36% May 2, 2002 - Aug 2, 2005
#2	-57.88% Nov 8, 2024 - Jul 7, 2026	-73.54% Apr 2, 2014 - Oct 29, 2025
#3	-18.72% May 16, 2024 - Jul 11, 2024	-73.10% Jul 21, 2008 - Sep 14, 2012
#4	-17.60% Mar 1, 2024 - Mar 28, 2024	-41.25% May 22, 2001 - Apr 25, 2002
#5	-13.35% Jul 16, 2024 - Oct 15, 2024	-40.31% Nov 18, 1999 - Aug 22, 2000
#6	-12.30% Apr 11, 2024 - May 8, 2024	-29.83% Feb 25, 2026 - May 19, 2026
#7	-9.31% Aug 23, 2018 - Sep 6, 2018	-21.25% May 10, 2006 - Apr 24, 2007
#8	-8.79% Feb 9, 2024 - Feb 27, 2024	-20.62% Dec 13, 2007 - Feb 20, 2008
#9	-7.55% Jul 18, 2018 - Jul 23, 2018	-17.19% Aug 8, 2007 - Sep 19, 2007
#10	-6.96% Dec 19, 2023 - Jan 9, 2024	-17.08% Jun 16, 2008 - Jul 14, 2008
#11	-6.46% Oct 22, 2024 - Nov 7, 2024	-16.74% Mar 7, 2001 - Apr 17, 2001
#12	-6.38% Jan 9, 2024 - Feb 8, 2024	-15.47% Feb 28, 2008 - Apr 7, 2008
#13	-5.82% May 8, 2024 - May 16, 2024	-15.35% Dec 12, 2000 - Dec 27, 2000
#14	-4.49% Aug 13, 2018 - Aug 17, 2018	-13.80% Sep 6, 2000 - Oct 30, 2000
#15	-4.26% Feb 28, 2024 - Mar 1, 2024	-11.57% Dec 31, 2013 - Feb 19, 2014